India may soon have more places to bring in medicines and medical devices from other countries. The government has proposed adding 10 new locations to India’s authorised import network for drugs, medical devices and cosmetics, including Noida International Airport. The move could make it easier for companies to import and clear healthcare products in the country. It may also help them clear imported goods closer to their warehouses and factories, saving time and transport costs. The proposal is still under review, and the government has not given final approval yet.
Noida International Airport May Handle Imported Medicines
One of the key proposals is to include Noida International Airport in Uttar Pradesh among the authorised entry points for drug imports by air. The Ministry of Health and Family Welfare has proposed allowing companies to import drugs by air through this airport. If the government approves the plan, Noida Airport could become another authorised entry point for drug imports in northern India.
This may help companies that store or distribute healthcare products in and around Delhi-NCR. Instead of moving shipments from airports farther away, they could have another option for bringing medicines into the country. However, the airport cannot handle drug imports under the proposed provision until the government finalises the amendment and the necessary arrangements are in place.
Which 10 New Locations May Handle Medicine Imports in India?
The government has proposed 10 new locations across several states. These include an international airport, inland container depots and a special economic zone. Here are the proposed locations:
| State | Proposed Import Entry Points |
| Uttar Pradesh | Noida International Airport, Dadri ICD |
| Haryana | Sonipat ICD, Piyala ICD, Harsaru ICD |
| Gujarat | Gandhidham/Mundra ICD |
| Telangana | Sanath Nagar ICD, Thimmapur ICD |
| Karnataka | Whitefield ICD, Bommasandra Special Economic Zone |
An Inland Container Depot (ICD) is a facility where companies can handle customs-related procedures for imported and exported goods at an inland location, away from a seaport or airport. These new locations would add to India’s existing medicine import network if the government approves the proposal.
Why Does India Want More Medicine Import Entry Points?
Under Rule 43A of the Drugs Rules, 1945, companies can import drugs into India through specified authorised entry points. Some of these places are far from their warehouses and factories. So, companies have to spend extra time and money moving their products. The government wants to make this process easier by adding more import points across the country.
For example, a company in Hyderabad may be able to use the proposed ICDs at Sanath Nagar or Thimmapur instead of bringing its medicines through a more distant entry point. This could save time, cut transport costs and make deliveries easier.
What Changes Are Proposed Under the Drugs Rules, 1945?
The Ministry of Health and Family Welfare has proposed an amendment to Rule 43A of the Drugs Rules, 1945. Rule 43A specifies the authorised ports, airports, railway stations, road crossings and other entry points through which drugs can be imported into India. The government now wants to add 10 more locations to the existing list of authorised import entry points.
The plan covers drugs, medical devices and cosmetics. India already has approved airports, seaports and inland container depots for these imports. The new locations would give companies more choices.
How Could the New Import Locations Help Healthcare Companies?
More import locations could make things easier for healthcare companies. If the government approves the plan, companies may be able to clear imported drugs and medical devices closer to their manufacturing facilities, warehouses and distribution centres. They may not have to move their shipments over such long distances. This could save money and help them deliver products on time.
However, the benefits will depend on how the new locations work and how long the required checks take.
When Will the New Medicine Import Entry Points Be Approved?
The government has not announced when the proposed amendment will be finalised. The Health Ministry has invited objections and suggestions on the draft amendment from stakeholders. Officials will consider the feedback before finalising the proposed changes. Until then, companies must continue using the existing authorised entry points to import medicines.
The draft amendment specifies that the changes will come into force on the date of their final publication in the Official Gazette.
What Could This Mean for India’s Healthcare Supply Chain?
If the plan gets approval, companies could have more options for importing drugs, medical devices and cosmetics into India. They may be able to choose an import point closer to their warehouse or distribution centre. This could reduce long-distance transport and make it easier to move products from one place to another. It may also help companies manage their medicine and medical device shipments better. But these changes will take effect only after the government publishes the final amendment in the Official Gazette.
India wants to add 10 new entry points for importing drugs, medical devices and cosmetics. The plan could help companies save time and money when clearing and transporting imported healthcare products. However, the government has not finalised the proposed amendment yet.
| Disclaimer: Indian Eagle claims no credit for the images featured on its blog site. All the visual content is copyrighted to its respective owners only. We mention the source name of the image whenever possible and found. However, if we miss acknowledging the owner’s source, please contact us. In case, owners don’t want us to use their images, we will remove them promptly. We believe in providing proper attribution to the original author, artist, and photographer. |
